Vasopressin receptor antagonists and their role in clinical medicine
Hyponatremia is the most common electrolyte abnormality in hospitalized patients. Its treatment is based not only on extracellular fluid volume status of patients but also on its pathogenetic mechanisms. Conventional treatment of hyponatremia like fluid restriction, which is useful in euvolemic and...
Main Authors: | Girish Narayen, Surya Narayan Mandal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=2;spage=183;epage=191;aulast=Narayen |
Similar Items
-
Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01) -
Vasopressin Receptor Antagonists (Vaptans) in Heart Failure
by: Piotr Lipiec, et al.
Published: (2019-01-01) -
Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells
by: Annarita Di Mise, et al.
Published: (2019-12-01) -
Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?
by: Renato De Vecchis, et al.
Published: (2016-10-01) -
The Use of Vaptans in Hyponatraemia
by: Corinna Giuliani, et al.
Published: (2014-07-01)